Sartorius Aktiengesellschaft (VIE:SATG)
Austria
· Delayed Price · Currency is EUR | Market Cap | 14.92B |
| Revenue (ttm) | 3.54B |
| Net Income (ttm) | 154.90M |
| Shares Out | n/a |
| EPS (ttm) | 2.24 |
| PE Ratio | 96.29 |
| Forward PE | 38.68 |
| Dividend | 0.73 (0.37%) |
| Ex-Dividend Date | Mar 27, 2026 |
| Volume | n/a |
| Average Volume | 10 |
| Open | 192.00 |
| Previous Close | 191.00 |
| Day's Range | 191.80 - 192.60 |
| 52-Week Range | 141.20 - 207.50 |
| Beta | n/a |
| RSI | 51.98 |
| Earnings Date | Feb 3, 2026 |
About VIE:SATG
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture... [Read more]
Financial Performance
In 2025, VIE:SATG's revenue was 3.54 billion, an increase of 4.66% compared to the previous year's 3.38 billion. Earnings were 154.90 million, an increase of 84.40%.
Financial StatementsNews
Sartorius Aktiengesellschaft (SOAGY) Q4 2025 Earnings Call Transcript
Sartorius Aktiengesellschaft (SOAGY) Q4 2025 Earnings Call Transcript
Sartorius: Consistent Performance And Market Resurgence - Valuation Falls
Sartorius AG (SARTF) is rebounding with strong bioprocess segment growth and improving profit margins, despite a challenging biopharma environment. Secular demand for biologics and increased manufactu...
7 Stocks Taking The Next Step To Be On Offense
Bio-Rad Laboratories was a positive contributor after the company reported steadier earnings than the market expected. PVH also remains our largest share repurchaser for the year after buying a teens ...
It's time to scoop up undervalued stocks in this critical sector of the economy
Expanding your horizons and considering neglected sectors can help you identify bargain opportunities while defending your investment portfolio from a stock-market decline.
Sartorius Aktiengesellschaft (SOAGY) Q3 2025 Earnings Call Transcript
Sartorius Aktiengesellschaft (OTCPK:SOAGY) Q3 2025 Earnings Call October 16, 2025 7:00 AM EDT Company Participants Petra Muller - Head of Investor Relations Michael Grosse - CEO & Chairman of the Exec...
Sartorius Shares Rise After Guidance Lift
Sartorius said it now expects 7% revenue growth for 2025, compared with 6% previously, as underlying net profit rose 17%.
Sartorius Aktiengesellschaft (SARTF) Q2 2025 Earnings Call Transcript
Sartorius Aktiengesellschaft (OTCPK:SARTF) Q2 2025 Earnings Conference Call July 22, 2025 7:00 AM ET Company Participants Alexandra Gatzemeyer - Head of the Lab Products & Services Division and Member...
Sartorius Aktiengesellschaft (SARTF) Q1 2025 Earnings Call Transcript
Sartorius Aktiengesellschaft (OTCPK:SARTF) Q1 2025 Earnings Conference Call April 16, 2025 7:00 AM ET Company Participants Joachim Kreuzburg - Chief Executive Officer Alexandra Gatzemeyer - Head of th...
Sartorius Aktiengesellschaft (SARTF) Q4 2024 Earnings Call Transcript
Sartorius Aktiengesellschaft (OTCPK:SARTF) Q4 2024 Earnings Call January 28, 2025 7:00 AM ET Company Participants Joachim Kreuzburg - Chief Executive Officer Florian Funck - Chief Financial Officer Re...
Betting on Growth: 4 Favorite Stocks From T. Rowe Price's Peter Bates
The manager of the Global Select Equity Strategy looks for high margins, cash generation, competitive advantages, and a long runway of growth.
Sartorius Aktiengesellschaft (SARTF) Q3 2024 Earnings Call Transcript
Sartorius Aktiengesellschaft (OTCPK:SARTF) Q3 2024 Earnings Conference Call October 17, 2024 7:00 AM ET Company Participants Joachim Kreuzburg - Chairman René Fáber - Chief Executive Officer Florian F...
Sartorius Aktiengesellschaft (SARTF) Q1 2024 Earnings Call Transcript
Sartorius Aktiengesellschaft (OTCPK:SARTF) Q1 2024 Earnings Conference Call April 18, 2024 7:00 AM ET Corporate Participants Dr. Joachim Kreuzburg - Chairman René Fáber - Chief Executive Officer Flori...
Sartorius Aktiengesellschaft (SARTF) Q4 2023 Earnings Call Transcript
Sartorius Aktiengesellschaft (SARTF) Q4 2023 Earnings Call Transcript
10 stocks for investors looking for ‘wonderful companies at a fair price'
As money managers talk about various methods of selecting quality companies, investors might also think about diversification, which can lower risk and broaden opportunities.
These 5 DAX index companies are in trouble as their stocks plunge
German stocks are not doing well as the economy goes through substantial challenges. The most recent data showed that business confidence has tumbled while manufacturing and services PMIs have remaine...
Sartorius Aktiengesellschaft (SARTF) Q2 2023 Earnings Call Transcript
Sartorius Aktiengesellschaft (OTCPK:SARTF) Q2 2023 Earnings Conference Call July 21, 2023 9:30 AM ET Company Participants Joachim Kreuzburg - Chairman of the Executive Board and Chief Executive Office...
Sartorius: A German Champion With A Discounted Price
Sartorius has been experiencing a demand decline since 2022. Sartorius serves a niche market, which gives it a strong moat. Sartorius benefits from the long-term tailwinds of its sector.
Sartorius Aktiengesellschaft (SARTF) Q1 2023 Earnings Call Transcript
Sartorius Aktiengesellschaft (SARTF) Q1 2023 Earnings Call Transcript.
Sartorius, Sartorius Stedim shares fall after Polyplus acquisition
Shares in German pharmaceutical and laboratory equipment supplier Sartorius AG and its France-listed subsidiary Sartorius Stedim Biotech SA DIM, -6.51% fell in opening trade on Friday after the compan...
Sartorius AG: Combating And Benefiting From Eroom's Law
Sartorius is a low volume, almost private business, but offers investors exposure to great fundamentals in healthcare. With qualities that separate them from larger peers, Sartorius may offer a better...
Sartorius Aktiengesellschaft (SARTF) Q4 2022 Earnings Call Transcript
Sartorius Aktiengesellschaft (OTCPK:SARTF) Q4 2022 Earnings Conference Call January 26, 2023 9:30 AM ET Company Participants Joachim Kreuzburg - Chairman of Exec. Board & CEO Rainer Lehmann - CFO, Mem...
Sartorius Aktiengesellschaft (SARTF) Q3 2022 Earnings Call Transcript
Sartorius Aktiengesellschaft (OTCPK:SARTF) Q3 2022 Earnings Conference Call October 19, 2022 9:30 AM ET Corporate Participants Joachim Kreuzburg - Chief Executive Officer Rainer Lehmann - Chief Financ...
Sartorius Aktiengesellschaft (SARTF) CEO Joachim Kreuzburg on Q2 2022 Results - Earnings Call Transcript
Sartorius Aktiengesellschaft (OTCPK:SARTF) Q2 2022 Earnings Conference Call July 21, 2022 9:30 AM ET Company Participants Joachim Kreuzburg - Chief Executive Officer Rainer Lehmann - Chief Financial O...
Sartorius AG: Buy The French Subsidiary Instead
Sartorius AG and Sartorius Stedim are a buy after a significant drawdown. Sartorius is operating in the fast-growing biopharmaceutical industry.
Sartorius AG (SARTF) CEO Joachim Kreuzburg on Q1 2022 Results - Earnings Call Transcript
Sartorius AG ( OTCPK:SARTF) Q1 2022 Results Conference Call April 21, 2022 9:30 AM ET Company Participants Joachim Kreuzburg - CEO Rainer Lehmann - CFO Conference Call Participants Delphine Le Louet ...